Centaurus Financial, Inc. Novo Nordisk A S Call Options Transaction History
Centaurus Financial, Inc.
- $1.45 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,813Shares Held
337MCall Options Held
11.1MPut Options Held
10.4M-
Jennison Associates LLC18.8MShares$1.28 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.05 Billion0.11% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$856 Million0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$827 Million0.08% of portfolio
-
Loomis Sayles & CO L P11.6MShares$784 Million1.26% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $153B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...